Ritanserin

Ritanserin is a thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one that is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used to treat a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action. Among its listed roles, it functions as a dopaminergic antagonist, a serotonergic antagonist, an antipsychotic agent, an anxiolytic drug, an antidepressant and an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor. It is an organofluorine compound, a member of piperidines and a thiazolopyrimidine. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Tiserton, Ritanserinum and R-55667. Its PubChem CID is 5074.

CAS No 87051-43-2
Molecular Formula C27H25F2N3OS
Molecular Weight 477.6 g/mol
Synonyms 6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one

Frequently Asked Questions